Associate Professor at Medical University of South Carolina, United States
Dr. Azizul Haque, Ph.D., is an Associate Professor and Health Research Scientist with an extensive background in microbiology, immunology, and cancer research. With over two decades of experience in academic, research, and mentorship roles, he has contributed significantly to both scientific research and the development of future scholars. 🌍📚
Professional profile
Education📚
Dr. Haque holds a B.S. in Biology and an M.S. in Microbiology from Dhaka University, Bangladesh. He earned his Ph.D. in Microbiology and Immunology from Saga Medical School, Japan, followed by postdoctoral research at Indiana University School of Medicine in Immunology, Inflammation, and Cancer. 🎓🔬
Professional Experience🏛️
Dr. Haque has held various roles, including Associate Professor at the Medical University of South Carolina (MUSC) and Health Research Scientist at the Ralph Johnson VA Medical Center. He has also served in key research positions at institutions such as the Hollings Cancer Center and Indiana University. His expertise in cancer immunotherapy and neurodegenerative diseases highlights his interdisciplinary research approach. 🏫💡
Research Interest🌐
Dr. Haque’s research focuses on immunology, inflammation, and cancer. He is particularly interested in melanoma, prostate cancer, and neurodegenerative diseases like multiple sclerosis. His work integrates cancer biology and immunology, aiming to develop therapeutic strategies that enhance immune responses against tumors. 🔬🧠
Awards and Honors🏆
While specific awards and honors are not listed, Dr. Haque’s appointments and roles in prestigious institutions, such as MUSC and VA Medical Center, reflect his recognition in the field. His contributions to student mentorship and cancer research are likely to have earned him accolades throughout his career. 🏆👨🏫
Achievements
- Global Education: Completed a Ph.D. in Microbiology & Immunology in Japan, with postdoctoral research in the USA, reflecting a well-rounded international academic background.
- Faculty Leadership: Associate Professor at the Medical University of South Carolina (MUSC) since 2010, playing a pivotal role in the Department of Microbiology and Immunology.
- Interdisciplinary Research: Dual appointment in the Departments of Microbiology/Immunology and Neurosurgery, contributing to cancer immunotherapy and neurodegenerative disease research.
- Health Research Scientist: Current Health Research Scientist at the Ralph Johnson VA Medical Center, focusing on immunological responses in cancer and inflammation.
- Mentorship and Training: Served as an advisor and committee member for over 25 PhD and MS students, significantly contributing to graduate education.
- Cancer Research Contributions: Made significant advances in the study of melanoma, prostate cancer, and multiple sclerosis, particularly in the area of immunological mechanisms.
- Collaboration with Research Centers: Member of key research centers such as Hollings Cancer Center and Walther Oncology Center, contributing to cutting-edge cancer research.
- International Teaching: Experience as a teaching assistant in Japan, as well as a long-standing mentor in graduate education programs at MUSC.
Publications top noted📜
- “New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection”
A. Haque, R. Polcyn, D. Matzelle, N.L. Banik
Brain Sciences, 2018 | Cited by: 231 🧠🔬
- “Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection”
M.A. Haque, T. Mizobuchi, K. Yasufuku, T. Fujisawa, R.R. Brutkiewicz
The Journal of Immunology, 2002 | Cited by: 214 🫁🦠
- “Absence of γ-Interferon–inducible Lysosomal Thiol Reductase in Melanomas Disrupts T Cell Recognition of Select Immunodominant Epitopes”
M.A. Haque, P. Li, S.K. Jackson, H.M. Zarour
The Journal of Experimental Medicine, 2002 | Cited by: 177 🎯🦠
- “Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration”
M. Chakrabarti, A. Haque, N.L. Banik, P. Nagarkatti
Brain Research Bulletin, 2014 | Cited by: 137 💊🧠
- “Neuron specific enolase: a promising therapeutic target in acute spinal cord injury”
A. Haque, S.K. Ray, A. Cox, N.L. Banik
Metabolic Brain Disease, 2016 | Cited by: 128 🚑🧬
- “Role of disulfide bonds in regulating antigen processing and epitope selection”
P. Li, M.A. Haque, J.S. Blum
The Journal of Immunology, 2002 | Cited by: 105 🧫⚙️
- “Microgravity control of autophagy modulates osteoclastogenesis”
Y. Sambandam, M.T. Townsend, J.J. Pierce, C.M. Lipman, A. Haque
Bone, 2014 | Cited by: 100 🦴🔬
- “Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65‐kDa heat shock protein”
M.A. Haque, S. Yoshino, S. Inada
European Journal of Immunology, 1996 | Cited by: 91 🐀🌡️
- “Differential expression of Smad7 transcripts identifies the CD4+ CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts”
T. Mizobuchi, K. Yasufuku, Y. Zheng, M.A. Haque
The Journal of Immunology, 2003 | Cited by: 90 🧬🫁
- “Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients”
S.A. Imam, M.K. Guyton, A. Haque
Journal of Neuroimmunology, 2007 | Cited by: 81 🧠🩺
- “Cutting edge: induction of the antigen-processing enzyme IFN-γ-inducible lysosomal thiol reductase in melanoma cells is STAT1-dependent but CIITA-independent”
P.W. O’Donnell, A. Haque
The Journal of Immunology, 2004 | Cited by: 76 🔬⚙️
- “Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition”
M.A. Haque, J.W. Hawes, J.S. Blum
The Journal of Immunology, 2001 | Cited by: 74 🧪👁️
